New diagnostic agents for use with PET imaging are improving identification of beta-amyloid, the brain plaque associated with Alzheimer’s disease. But there are some concerns about training to accurately read these studies.
New radioactive diagnostic agents for use with PET imaging are improving identification of beta-amyloid, the brain plaque associated with Alzheimer’s disease. But there are some concerns that radiologists and technologists don’t have enough training to accurately read these PET studies. What do you think?
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.